Recovery Capacity Diagnostic Calibration: European Energy and Healthcare Systems

Both calibration cases follow the same protocol established in WP-004 Appendix A. The protocol is reproduced here in condensed form to establish the terms under which results should be interpreted.

3.1 Variation

Both cases show declining variation across the observation period. In the energy case, supply source HHI increased monotonically 2018–2021, with Russian pipeline gas rising from approximately 40% to over 44% of EU imports. In the healthcare case, care pathway diversity declined across all six countries through centralisation of acute care, reduction in primary care relative capacity, and workforce specialisation that reduced triage flexibility.

The mechanism differs between domains — market consolidation in energy, planned efficiency reform in healthcare — but the structural outcome is identical: fewer available pathways for equivalent system function under stress conditions.

3.2 Redundancy

This is the strongest signal across both cases and the most consistently documented in pre-event public data.

In the energy case, EU gas storage winter minimum fill rates declined across three consecutive annual cycles. Summer refill campaigns consistently failed to restore prior-year buffer baselines. By the blind cutoff date, storage headroom for multi-month disruption absorption had reached its lowest observed level.

In the healthcare case, the pattern is more uniform and covers a longer period. OECD data documents consistent bed reduction across the EU throughout the 2010s, with occupancy rates rising to compensate. By 2019, average acute care bed occupancy in the study countries exceeded levels at which clinical guidance identifies systemic strain risk. ICU capacity had not grown proportionally with population or age-adjusted demand.

3.3 Recovery Time

Recovery time elongation — the progressive slowing of return to baseline after disruption — was the most operationally visible signal in both cases, and the one most extensively documented in pre-event reports that nevertheless did not trigger systemic response.

In the energy case, TTF post-shock recovery duration increased from approximately 12 days in early 2018 to 38 days after the February 2021 cold event. The October 2021 spike had not recovered to pre-shock baseline by the blind cutoff date. In the healthcare case, winter pressure periods produced progressively longer elective care backlogs in each successive year from 2015 to 2019. Annual reports from national health systems documented this pattern consistently; it was attributed to demand growth rather than capacity erosion.

The five WP-004 early warning signals are assessed across both cases. Assessment uses only pre-cutoff evidence.

Both calibration cases share a finding that is not about the specific domains but about the diagnostic structure itself. In both cases, the exposure event — the 2022 gas disruption and the COVID pandemic stress — was widely described at the time as an unexpected shock. In both cases, the pre-event data shows a system whose recovery capacity had been declining for multiple years before the shock occurred.

This distinction has methodological implications beyond these two cases. If the pattern is general — if exposure events are detectors of prior recovery capacity deficit rather than causes of it — then the relevant diagnostic question shifts from post-event analysis ("what caused this?") to pre-event observation ("is the gradient negative?"). This is the operational implication of the gradient hypothesis, and it is what makes RP-3 the methodologically decisive next test.

RP-3 requires identifying a system in which the gradient was negative and the signals were present, but the exposure event either did not occur or did not produce systemic failure. If such cases exist and the framework cannot distinguish them from RP-1 and RP-2, the framework produces false positives and its diagnostic utility is limited. If the framework can identify structural differences between RP-1/RP-2 cases and RP-3 cases, it has earned a stronger evidential claim.

The limitations of individual cases documented in Appendix A apply here. Three cumulative limitations specific to the two-case comparison are added.

RP-3 is the false positive test: a system in which the WP-004 diagnostic signals were present and the gradient was negative, but systemic failure did not follow. This report establishes the pre-registration conditions for RP-3 before case selection occurs.